
Teva: Warren Buffett Likely Made A Mistake Selling Shares
dima_zel On November 3, 2022, Teva Pharmaceutical (NYSE:NYSE:TEVA) released its Q3 2022 financial report, demonstrating that the business strategy built under the leadership of Kåre Schultz is helping to reduce debt and the effects of […]